Skyrocketing health care prices have led a growing number of countries to follow Britain’s example when asking the hardest of questions: How much is life worth?
In the first such step by a major medical center, the clinic says it has begun publicly disclosing the business relationships its staff has with drug makers.
Skyrocketing health care prices have led a growing number of countries to follow Britain’s example when asking the hardest of questions: How much is life worth?
The European Union accused drug companies of adding billions of dollars to health care costs by delaying or blocking the sale of less-expensive generic medicines.